Время;Мероприятие
9:00–10:30;Форум молодых ученых "Future of Biomedicine: Young, FOBY
10:30–10:50;Кофе-брейк
10:50–14:10;Секция: Биомолекулы и разработка лекарств
10:50–11:10;Пленарный доклад: Козлов Сергей Александрович
11:10–11:30;Пленарный доклад: Силантьев Владимир Евгеньевич
11:30–11:50;Пленарный доклад: Гущин Иван Юрьевич
11:50–12:10;Пленарный доклад: Кокоев Леонид Александрович
12:10–12:22;Слонова Дарья Александровна: "Antibacterial and wound-healing effects of interferon-α2b and endolysin GRC-ML07 in an immunosuppressed mouse model"
12:22–12:34;Рябчевская Екатерина Михайловна: "The development of SARS-CoV-2 recombinant proteins for subunit vaccine and analysis of its antigenic properties with immune sera from Wuhan-, Delta- or Omicron-recovered donor"
12:34–12:46;Козловская Любовь Игоревна: "In vitro systems for phenotypic screening of small molecules against RNA viruses"
12:46–12:58;Осолодкин Дмитрий Иванович: "Novel Antiviral Chemotypes from the Catalogues of Commercially Available Compounds"
12:58–13:10;Прошин Павел Игоревич: "Targeted Drug Delivery via Biodegradable Multilayered Films: PLACE Technology for Controlled Local Release"
13:10–13:22;Андреев Ярослав Алексеевич: "TRPV1 channel modulators for the treatment of neurodegenerative diseases"
13:22–13:34;Кашеверов Игорь Евгеньевич: "Ligands of nicotinic acetylcholine receptors as a basis for the development of potential drugs"
13:34–13:46;Сачивкина Надежда Павловна: "Reduced virulence of mutant strains of Cryptococcus neoformans in vivo and in vitro"
14:10–15:10;Обед
15:10–18:40;Секция: Персонализированная терапия в онкологии
15:10–15:30;Пленарный доклад: Литвяков Николай Васильевич
15:30–15:50;Пленарный доклад: Григорьева Эльвира Витальевна
15:50–16:02;Кулигина Елена Владимировна: "Results of Phase I Clinical Trials of Oncolytic Virus VV-GMCSF-Lact"
16:02–16:14;Дымова Майя Александровна: "Aptamers as tools for increasing the antitumor efficacy of the oncolytic virus VV-GMCSF-Lact"
16:14–16:26;Кошманова Анастасия Андреевна: "Aptamers for Glial Tumor Targeted Therapy"
16:26–16:38;Слепцова Екатерина Евгеньевна: "Photodynamically induced glioma cell death as a basis for antitumor immunotherapeutic strategy"
16:38–16:50;Яголович Анна Валерьевна: "Dual targeting of malignant cells and tumor microenvironment with multispecific fusion proteins binding DR5, VEGFR, and FGFR Receptors"
16:50–17:02;Малюченко Наталия Валериевна: "Effect of synthetic and natural epigenetically active compounds on PARP1 functions as a target for anticancer therapy"
17:02–17:14;Штам Татьяна Александровна: "Plant Vesicles — Effective Delivery Systems for Therapeutic Proteins to Activate Antitumor Immune Response"
17:14–17:26;Цыганов Матвей Михайлович: "The role of alterations gene the homologous recombination system in the treatment of patients with non-small cell lung cancer"
17:26–17:38;Мирошниченко Светлана Константиновна: "Exploring the best-responding types of malignancies for the microRNA-targeted mesyl oligonucleotides"
17:38–17:50;Патутина Ольга Александровна: "Antitumor potential of microRNA-targeted therapy in colorectal cancer"
17:50–18:02;Стяжкина Елена Владимировна: "Liposomal Targeted Nanostructures for Radionuclide Cancer Therapy"
18:02–18:14; Мушенкова Наталия Валентиновна: "Identification and in vitro characterization of TCR, specific to oncogenic driver mutations"
19:30-24:00;Социальная программа: Гала-ужин в ресторане "Круиз", б. Шамора